论文部分内容阅读
以前,曾有关于溶菌酶作为慢性炎症活动性指征的报道,但关于在慢性肝炎和肝硬变中溶菌酶的研究较少。本文研究了在肝脏疾患中血清溶菌酶和肝脏组织溶菌酶的分布情况。全部病人均经活体检查。32名原发性胆汁性肝硬变病人,14名慢性肝炎病人(慢性活动性肝炎和慢性迁延性肝炎),15名其它肝脏疾患病人(肝癌、肝纤维化、酒精性肝病、药物性肝炎、肝外胆汁郁滞等)及47名对照病人检查血清溶菌酶。20名原发性胆汁
Previously, there have been reports of lysozyme as an indication of chronic inflammatory activity, but less on lysozyme in chronic hepatitis and cirrhosis. This article studies the distribution of lysozyme in serum and liver lysozyme in liver disease. All patients were biopsied. 32 patients with primary biliary cirrhosis, 14 patients with chronic hepatitis (chronic active hepatitis and chronic persistent hepatitis) and 15 patients with other liver disorders (liver cancer, liver fibrosis, alcoholic liver disease, drug-induced hepatitis, Extrahepatic cholestasis, etc.) and 47 control patients examined serum lysozyme. 20 primary bile